EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes

Yun-Ah Lee, Sung-Goo Kang iD

Nutrients · 2026

DOI: 10.3390/nu18193167 ↗

At a glance

Übersichtsarbeit in Nutrients, 2026. Written by Yun-Ah Lee and 1 co-authors. Institution: Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 16247, Republic of Korea. Major MEDLINE topics: Homocysteine, Vitamin D, Cardiovascular Diseases. 69 references. The full text is freely available (open access, CC BY 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The clinical relevance of a proposed relationship between vitamin D status and homocysteine remains uncertain. This narrative review integrates mechanistic, observational, Mendelian randomization (MR), and trial evidence. A documented supplementary search of PubMed and Europe PMC was executed on 21 September 2026 for publications through 31 July 2026; no formal risk-of-bias assessment or quantitative synthesis was performed. Experimental studies support vitamin D-dependent regulation of homocysteine metabolism and homocysteine-related suppression of vitamin D signaling, but reciprocal regulation has not been established in humans. Human biomarker associations and supplementation effects on homocysteine are heterogeneous; two frequently cited intervention publications report the same trial. Additional longitudinal and multibiomarker studies provide preliminary outcome associations, without externally validating the proposed four-category classification or its treatment utility. Homocysteine MR signals are more consistent for stroke than coronary disease, subject to validity and multiplicity concerns. Vitamin D MR is predominantly null, including the republished stratified analysis, and large supplementation trials have not demonstrated consistent cardiovascular benefit. A combined folate–vitamin D cognitive trial did not demonstrate its primary intention-to-treat benefit and does not validate vascular treatment selection. Clinical outcome trials carry greater weight for treatment decisions than molecular plausibility or biomarker co-occurrence. The proposed classification and explanatory models remain hypothesis-generating: a clinically meaningful reciprocal axis and differential benefit from phenotype-guided combined nutritional intervention are unproven.

Subjects

MeSH terms (MEDLINE)

HomocysteineVitamin DCardiovascular DiseasesHumansBiomarkersPhenotypeMendelian Randomization AnalysisDietary Supplements

Author keywords

25-hydroxyvitamin DMendelian randomizationcardiovascular diseaseendothelial dysfunctionhomocysteinehypothesis-generating biomarker profilesone-carbon metabolismprecision nutritionvitamin D

Substances

HomocysteineVitamin DBiomarkers

Authors and institutions

  • Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 16247, Republic of Korea.

ORCID profiles: Sung-Goo Kang

Cite

APA

Lee, Y. A., & Kang, S. G. (2026). The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes. Nutrients. https://doi.org/10.3390/nu18193167

Vancouver

Lee YA, Kang SG. The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes. Nutrients. 2026. doi:10.3390/nu18193167

BibTeX
@article{Lee2026,
  author = {Lee, Yun-Ah and Kang, Sung-Goo},
  title = {The Proposed Vitamin D–Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18193167}
}
Start for free →